Mucositis after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation

被引:4
作者
Busemann, Christoph [1 ]
Wilfert, Hanna [1 ]
Neumann, Thomas [1 ]
Kiefer, Thomas [1 ]
Doelken, Gottfried [1 ]
Krueger, William H. [1 ]
机构
[1] Ernst Moritz Arndt Univ Greifswald, Univ Hosp Greifswald, Dept Internal Med Haematol Oncol & Stem Cell Tran, D-17475 Greifswald, Germany
来源
ONKOLOGIE | 2011年 / 34卷 / 10期
关键词
Allogeneic stem cell transplantation; Conditioning therapy; Mucositis; Transplant-related morbidity; Toxicity; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; HIGH-DOSE CHEMOTHERAPY; TOTAL-BODY IRRADIATION; ORAL MUCOSITIS; MYCOPHENOLATE-MOFETIL; UNRELATED DONORS; METHOTREXATE; FLUDARABINE; LYMPHOMA;
D O I
10.1159/000332131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Therapy-related mucositis is associated with considerable morbidity. This complication following allogeneic stem cell therapy (allo-SCT) is less severe after reduced intense conditioning (RIC); however, even here it may be serious. Methods: 52 patients (male: n = 35 (67%), female: n = 17 (33%)) at a median age of 62 years (35-73 years) underwent allo-SCT after RIC. Conditioning was either total body irradiation (TBI)(2Gy)/+/- fludarabine (n = 33, 63.5%) or chemotherapy based. Graft-versus-host disease (GvHD) prophylaxis was carried out with cyclosporine A +/- mycophenolate mofetil (MMF). 45 patients (87%) received short-course methotrexate (MTX). Mucositis was graded according to the Bearman and the World Health Organisation (WHO) scale. A variety of parameters were correlated with mucositis. Results: The Bearman and WHO scales showed excellent correlation. Mucositis was significantly more severe after chemotherapy-based conditioning compared to conditioning with TBI(2Gy)/+/- fludarabine (p < 0.002) as well as in cases with an increase in creatinine levels above the upper normal value (UNV) on day + 1 after SCT (p < 0.05). Furthermore, the severity correlated with time to engraftment of leucocytes (correlation coefficient (cc) = 0.26, p < 0.02) and thrombocytes (cc = 0.38, p < 0.001). Conclusions: The conditioning regimen and increased creatinine levels at day + 1 were identified as factors predicting the severity of mucositis after RIC-SCT. Creatinine levels on day + 1 after SCT may help identify patients at risk for severe mucositis in the further course of transplantation.
引用
收藏
页码:518 / 524
页数:7
相关论文
共 24 条
  • [1] Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review
    Baron, F
    Storb, R
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 26 (1-2): : 71 - 94
  • [2] REGIMEN-RELATED TOXICITY AND EARLY POSTTRANSPLANT SURVIVAL IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR LYMPHOMA
    BEARMAN, SI
    APPELBAUM, FR
    BACK, A
    PETERSEN, FB
    BUCKNER, CD
    SULLIVAN, KM
    SCHOCH, HG
    FISHER, LD
    THOMAS, ED
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) : 1288 - 1294
  • [3] Treatment of invasive fungal infections in cancer patients-Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Boehme, Angelika
    Ruhnke, Markus
    Buchheidt, Dieter
    Cornely, Oliver A.
    Einsele, Herrmann
    Enzensberger, Ruxandra
    Hebart, Holger
    Heinz, Werner
    Junghanss, Christian
    Karthaus, Meinolf
    Kruger, William
    Krug, Utz
    Kubin, Thomas
    Penack, Olaf
    Reichert, Dietmar
    Reuter, Stefan
    Silling, Gerda
    Sudhoff, Thomas
    Ullmann, Andrew J.
    Maschmeyer, Georg
    [J]. ANNALS OF HEMATOLOGY, 2009, 88 (02) : CP6 - 110
  • [4] A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
    Bolwell, B
    Sobecks, R
    Pohlman, B
    Andresen, S
    Rybicki, L
    Kuczkowski, E
    Kalaycio, M
    [J]. BONE MARROW TRANSPLANTATION, 2004, 34 (07) : 621 - 625
  • [5] Mini-allografts: ongoing trials in humans
    Carella, AM
    Champlin, R
    Slavin, S
    McSweeney, P
    Storb, R
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (04) : 345 - 350
  • [6] Treosulfan and fludarabine:: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Casper, J
    Knauf, W
    Kiefer, T
    Wolff, D
    Steiner, B
    Hammer, U
    Wegener, R
    Kleine, HD
    Wilhelm, S
    Knopp, A
    Hartung, G
    Dölken, G
    Freund, M
    [J]. BLOOD, 2004, 103 (02) : 725 - 731
  • [8] Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing Graft-versus-host disease prophylaxis regimens
    Cutler, C
    Li, SL
    Kim, HT
    Laglenne, P
    Szeto, KC
    Hoffmeister, L
    Harrison, MJ
    Ho, V
    Alyea, E
    Lee, SJ
    Soiffer, R
    Sonis, S
    Antin, JH
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (05) : 383 - 388
  • [9] GROSFLAM J, 1991, Current Opinion in Rheumatology, V3, P363, DOI 10.1097/00002281-199106000-00006
  • [10] Nonmyeloablative stem cell transplantation for lymphoma
    Khouri, IF
    Champlin, RE
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 22 - 26